WO2022052191A1 - Histidinol-phosphate aminotransferase mutant, engineering bacteria and use - Google Patents

Histidinol-phosphate aminotransferase mutant, engineering bacteria and use Download PDF

Info

Publication number
WO2022052191A1
WO2022052191A1 PCT/CN2020/118927 CN2020118927W WO2022052191A1 WO 2022052191 A1 WO2022052191 A1 WO 2022052191A1 CN 2020118927 W CN2020118927 W CN 2020118927W WO 2022052191 A1 WO2022052191 A1 WO 2022052191A1
Authority
WO
WIPO (PCT)
Prior art keywords
histidine
mutant
concentration
phosphate aminotransferase
medium
Prior art date
Application number
PCT/CN2020/118927
Other languages
French (fr)
Chinese (zh)
Inventor
王东阳
廖佳伟
陈正
张娟
冯志彬
Original Assignee
山东阳成生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 山东阳成生物科技有限公司 filed Critical 山东阳成生物科技有限公司
Publication of WO2022052191A1 publication Critical patent/WO2022052191A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1096Transferases (2.) transferring nitrogenous groups (2.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • C12N15/1031Mutagenizing nucleic acids mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y206/00Transferases transferring nitrogenous groups (2.6)
    • C12Y206/01Transaminases (2.6.1)
    • C12Y206/01009Histidinol-phosphate transaminase (2.6.1.9)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the invention relates to histidine alcohol phosphate aminotransferase mutants, engineering bacteria and applications, and belongs to the field of biotechnology.
  • Oxidative deamination using L-amino acid oxidase is also an important method for synthesizing IPA, but the by-product hydrogen peroxide will lead to the degradation of IPA, and the yield and purity are difficult to guarantee.
  • Patent CN200880104143.X utilizes Escherichia coli engineering to express the amino acid oxidase derived from Providencia rettgeri AJ2770 strain, transforms L-tryptophan to produce IPA, and in the 200mmol/L substrate tryptophan reaction system, The highest concentration of IPA was only 129 mM, and the product yield was low.
  • Transaminase also known as aminotransferase (Aminotransferase)
  • aminotransferase Aminotransferase
  • the technical problem to be solved by the present invention is to provide a histidine alcohol phosphate aminotransferase-producing mutant, recombinant bacteria and whole cells thereof as catalysts for the synthesis of 3-indolepyruvic acid.
  • the mutant is one of the following, the 66th valine is mutated to isoleucine (hisC-V66I), the 138th asparagine is mutated to glutamine (hisC-N138Q), the 197th serine Histidine phosphate aminotransferase mutated to histidine (hisC-S197H) or proline 226 to phenylalanine and arginine 311 to tyrosine (hisC-P226F-R311Y)
  • the mutant more preferably the mutant is hisC-P226F-R311Y.
  • the present invention also relates to a gene encoding the histidine alcohol phosphate aminotransferase mutant.
  • the present invention provides engineered bacteria containing the encoded gene.
  • the present invention also provides an application of the histidine alcohol phosphate aminotransferase mutant in catalyzing the synthesis of 3-indolepyruvate from L-tryptophan.
  • the described application method is to use the bacterial cell harvested by fermentation and centrifugation of the engineered bacteria containing the histidine alcohol phosphate aminotransferase mutant gene as a whole-cell catalyst, use L-tryptophan as a substrate, and use L-chromogen as a substrate.
  • Pyruvate with an amino acid molar concentration of 1.2 times is an amino acceptor, adding 25mg/L coenzyme pyridoxal phosphate, 1g/L stabilizing protective agent to the conversion system, ammonia water is adjusted to pH 7.5, nitrogen is used to drive oxygen, and the temperature is 30
  • the reaction produces 3-indolepyruvic acid under the condition of ⁇ 40°C.
  • the amount of catalyst used is 10-40 g/L in terms of wet cell weight, the substrate concentration is 50-200 mM, and the pyruvate concentration is 60-240 mM.
  • the engineered bacteria containing the histidine alcohol phosphate aminotransferase mutant gene are prepared as follows: the recombinant Escherichia coli containing the histidine alcohol phosphate aminotransferase mutant gene is inserted into the LB slant medium and cultured at 37°C for 12 to 18 hours; Connect 1 ring of slanted inoculum to LB liquid seed medium, shake at 37°C and 180r/min for 4-10h; put 2.0L of medium into a 3L fermenter, and insert the seed liquid with a volume ratio of 2-12% of the inoculum. Fermentation medium, the initial rotation speed is 220r/min, and the initial ventilation flow rate is 1.0L/min.
  • the rotation speed and ventilation flow rate are adjusted to maintain the dissolved oxygen value at 20-30% air saturation.
  • the mass-volume ratio is 25% ammonia water was used to adjust the pH value to be stable at 6.7.
  • lactose was added to the final concentration of 1-5g/L and cooled to 20-30°C to induce expression; during the fermentation process, 500g/L glycerol solution was added to maintain glycerol.
  • the cells were collected by centrifugation at 10,000 r/min and 4°C for 10 min, and washed twice with sterile saline to obtain histidine alcohol phosphate aminotransferase mutant whole-cell catalysts.
  • composition and final concentration of the LB slant medium yeast extract powder 5g/L, peptone 10g/L, NaCl 5g/L, ampicillin 100mg/L, agar 20g/L, pH7.0 ⁇ 7.2, 121 °C high pressure steam sterilization for 20min;
  • composition and final concentration of the LB liquid seed medium yeast extract powder 5g/L, peptone 10g/L, NaCl 5g/L, ampicillin 100mg/L, pH7.0 ⁇ 7.2, 121 °C of high pressure steam sterilization bacteria 20min;
  • the stabilizing protective agent is one or a combination of sodium sulfite and phytic acid.
  • the invention adopts the error-prone PCR technology to successfully mutate the histidine alcohol phosphate aminotransferase derived from Streptomyces garciniae and constructs an engineering strain.
  • the screened mutant enzyme activity is up to 120% higher than the original, and is used for 3-indole
  • the stability of 3-indolepyruvic acid is effectively improved through the combined use of nitrogen-filled protection and stabilizer.
  • the raw materials used in the production method of the present invention are cheap and easy to obtain, the production process is simple and feasible, and the production cost is low.
  • the established whole-cell transformation system solves the problems of harsh reaction conditions for chemical synthesis of IPA, complicated product purification, low yield, environmental pollution risks of by-products, and the influence of L-amino acid oxidase by-product hydrogen peroxide on the product. Destroy the impact and achieve high-yield green production of IPA.
  • the biological deposit number is CGMCC 15060 (this strain has been biologically deposited and disclosed in the patent 2018100327172 before the application date) gene hisC sequence (SEQ ID No. 1) is designed to contain Nco I digestion
  • Bacterial genomic DNA extraction kit was used to extract the genomic DNA of Streptomyces garcinata, and the genomic DNA was used as a template for PCR amplification.
  • the PCR reaction system included 2 ⁇ GC Buffer I 25 ⁇ L, dNTP Mix 8 ⁇ L, TaKaRa LA Taq 0.5 ⁇ L, template 0.5 ⁇ L, upstream and downstream primers 1.0 ⁇ L each, supplemented to 50 ⁇ L with dd H 2 O.
  • PCR reaction parameters were: 94°C for 1 min, 1 cycle; 94°C for 30 s, 60°C for 30 s, 72°C for 2 min, 30 cycles; 72°C for 5 min, 1 cycle.
  • PCR amplification products were detected by 1% agarose gel, and target DNA fragments were purified by AxyPrep DNA gel recovery kit.
  • the vector pET32a and its fragment were digested with Nco I and Xho I, respectively, and then the hisC fragment was ligated with the vector with T4 DNA ligase and transformed into E. coli DH5 ⁇ . After the positive clones were verified by colony PCR and enzyme digestion, the pET32a-hisC recombinant vector was obtained.
  • the recombinant vector pET32a-hisC was used as a template for amplification by error-prone PCR.
  • the reaction system of error-prone PCR is: PCR Grade Water 39 ⁇ L, 10 ⁇ TITANIUM Taq Buffer 5 ⁇ L, MnSO4 (8mM) 1 ⁇ L, dGTP (2mM) 1 ⁇ L, 50 ⁇ Diversify dNTP Mix 1 ⁇ L, Primer mix 1 ⁇ L, Template 1 ⁇ L, TITANIUM Taq Polym 1 ⁇ L , a total of 50 ⁇ L of the system (wherein the Primer mix in the reaction system is a mixed solution of 0.5 ⁇ L of each of the upstream and downstream primers described in Example 1).
  • the error-prone PCR reaction conditions were: 94°C for 30s, 1 cycle; 94°C for 30s, 68°C for 1min30s, 25 cycles; 68°C for 1min, 1 cycle. Error-prone PCR amplification products were detected on a 1% agarose gel and purified using the AxyPrep DNA Gel Recovery Kit.
  • the vector pET32a and the amplified product were digested with Nco I and Xho I respectively, and then the amplified product was connected with the vector with T4 DNA ligase, and the connected recombinant vector was thermally transferred into E.coli BL21 (DE3) competent cells, The cells were incubated at 37°C at 200 r/min for 1 h for activation, and the activated recombinant cells were spread on LB plates containing 0.1 mg/mL ampicillin resistance, and incubated overnight at 37°C upside down to obtain histidine alcohol amino phosphate. Transferase mutant expression library.
  • the specific screening method is as follows: randomly pick 600 single colonies from the plate, insert it into a 96-deep-well plate, the medium is LB liquid medium, cultivate at 37°C for 9 hours at 180 r/min, collect the bacteria by centrifugation, and remove the supernatant. Fermentation medium was added after the medium, cultured at 37°C, 220r/min for 6h, lactose was added to the final concentration of 2g/L, and the temperature was lowered to 20°C to induce expression; the cells were collected by centrifugation, and the enzyme activity was determined.
  • Standard enzyme activity detection system 25g/L wet bacterial cells, 50mM substrate L-tryptophan, 25mg/L coenzyme pyridoxal phosphate, 60mM pyruvate, the reaction medium is phosphate buffer at pH 7.5, and the total system is 1mL .
  • unit enzyme activity Under standard reaction conditions, the amount of enzyme required to generate 1 ⁇ mol of 3-indolepyruvate per minute is one unit of enzyme activity U.
  • histidine alcohol phosphate aminotransferase mutant strains were obtained by screening, and after sequencing, the 66th valine in the amino acid sequence shown in SEQ ID NO: 2 was mutated to isoleucine (hisC-V66I), the Asparagine 138 was mutated to glutamine (hisC-N138Q), serine 197 was mutated to histidine (hisC-S197H), proline 266 was mutated to phenylalanine, and arginine 311 was mutated Histidine alcohol phosphate aminotransferase mutants mutated to tyrosine (hisC-P226F-R311Y), the corresponding engineering strains are E.coli BL21(DE3)/pET32a-hisC-V66I, E.coli BL21(DE3) /pET32a-hisC-N138Q, E.coli BL21(DE3)/pET32a-hisC-S197H, E.coli BL21(DE3)
  • Example 2 Production of histidine alcohol phosphate aminotransferase mutants (hisC-N138Q, hisC-P226F-R311Y) by recombinant bacteria fermentation and enzymatic transformation of L-tryptophan to produce IPA
  • E.coli BL21(DE3)/pET32a-hisC-N138Q and E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y were respectively inserted into LB slant medium and cultured at 37°C for 18h; Planted in LB liquid seed medium, 37°C, 180r/min shaking culture for 9h; 2.0L medium was placed in a 3L fermenter, the seed liquid was inserted into the fermentation medium at a volume ratio of 4% inoculum, and the initial speed was 220r/min , the initial ventilation flow is 1.0L/min, and the speed and ventilation flow are adjusted with the increase of bacterial concentration to maintain the dissolved oxygen value at 20-30% air saturation, and the pH value is stabilized at 6.7 with a mass-volume ratio of 25% ammonia water.
  • Example 3 Production of histidine alcohol phosphate aminotransferase mutant (hisC-P226F-R311Y) by recombinant bacteria fermentation and enzymatic transformation of L-tryptophan to produce IPA
  • the genetically engineered bacteria E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y was inserted into LB slant medium for 15 hours at 37°C; then a ring of slant strains was placed in LB liquid seed medium at 37°C, 180r /min shaking culture for 10h; 2.0L medium was placed in the 3L fermenter, the seed liquid was inserted into the fermentation medium at a volume ratio of 5% inoculum, the initial speed was 220r/min, and the initial ventilation flow was 1.0L/min.
  • the concentration of bacteria was increased to adjust the rotational speed and ventilation flow to maintain the dissolved oxygen value at 20-30% air saturation.
  • the pH value was adjusted to 6.7 with a mass-volume ratio of 25% ammonia water. After culturing at 37 °C for 4 hours, lactose was added to the final concentration of 1 g/L and cooled to 22 °C to induce expression; during the fermentation process, 500 g/L glycerol solution was added to maintain the glycerol concentration at 5-10 g/L. After the fermentation, the cells were collected by centrifugation at 10000 r/min and 4 °C for 10 min, and sterile saline was used. The cells were washed twice to obtain the whole cell catalyst.
  • Example 4 Production of histidine alcohol phosphate aminotransferase mutant (hisC-P226F-R311Y) by recombinant bacteria fermentation and enzymatic transformation of L-tryptophan to produce IPA
  • the genetically engineered bacteria E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y was inserted into LB slant medium for 15 hours at 37°C; then a ring of slant strains was placed in LB liquid seed medium at 37°C, 180r /min shaking culture for 10h; 2.0L medium was placed in the 3L fermenter, the seed liquid was inserted into the fermentation medium at a volume ratio of 5% inoculum, the initial speed was 220r/min, and the initial ventilation flow was 1.0L/min.
  • the concentration of bacteria was increased to adjust the rotational speed and ventilation flow to maintain the dissolved oxygen value at 20-30% air saturation.
  • the pH value was adjusted to 6.7 with a mass-volume ratio of 25% ammonia water. After culturing at 37 °C for 4 hours, lactose was added to the final concentration of 1 g/L and cooled to 22 °C to induce expression; during the fermentation process, 500 g/L glycerol solution was added to maintain the glycerol concentration at 5-10 g/L. After the fermentation, the cells were collected by centrifugation at 10000 r/min and 4 °C for 10 min, and sterile saline was used. The cells were washed twice to obtain the whole cell catalyst.
  • Example 5 Production of histidine alcohol phosphate aminotransferase mutant (hisC-P226F-R311Y) by recombinant bacteria fermentation and enzymatic transformation of L-tryptophan to produce IPA
  • the genetically engineered bacteria E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y was inserted into LB slant medium for 14 hours at 37°C; then a ring of slant strains was placed in LB liquid seed medium at 37°C, 180r /min shaking culture for 8h; 2.0L medium was placed in the 3L fermenter, the seed liquid was inserted into the fermentation medium at a volume ratio of 5% inoculum, the initial rotation speed was 220r/min, and the initial ventilation flow was 1.0L/min.
  • the concentration of bacteria was increased to adjust the rotational speed and ventilation flow to maintain the dissolved oxygen value at 20-30% air saturation.
  • the pH value was adjusted to 6.7 with a mass-volume ratio of 25% ammonia water. After culturing at 37 °C for 4 hours, lactose was added to the final concentration of 4g/L and cooled to 20°C to induce expression; during the fermentation process, 500g/L glycerol solution was added to maintain the glycerol concentration at 5-10g/L. After the fermentation, the cells were collected by centrifugation at 10,000r/min and 4°C for 10min, and sterile saline The cells were washed twice to obtain the whole cell catalyst.
  • Nitrogen was used to drive oxygen for 15 min, the temperature was maintained at 37 °C, and the reaction was carried out in a 3 L fermentor for 12 h.
  • the concentration of IPA was 179.8 mM, and the molar conversion rate was 89.9%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

A histidinol-phosphate aminotransferase mutant, engineering bacteria and the use of the histidinol-phosphate aminotransferase mutant in the production of indole-3-pyruvic acid. A histidinol-phosphate aminotransferase gene is derived from a Streptomyces luteoverticillatus strain HY61, and the nucleotide sequence of the gene is as shown in SEQ ID NO: 1, and the amino acid sequence of the gene is as shown in SEQ ID NO: 2. The mutant is obtained by means of single mutation or multi-site mutations at position 66, position 138, position 197, position 226 and position 311 of the amino acid sequence as shown in SEQ ID NO: 2.

Description

一种组氨醇磷酸氨基转移酶突变体、工程菌及应用A kind of histidine alcohol phosphate aminotransferase mutant, engineering bacteria and application 技术领域technical field
本发明涉及组氨醇磷酸氨基转移酶突变体、工程菌及应用,属于生物技术领域。The invention relates to histidine alcohol phosphate aminotransferase mutants, engineering bacteria and applications, and belongs to the field of biotechnology.
背景技术Background technique
3-吲哚丙酮酸(IPA)是重要的中间体化合物,是制造3-吲哚乙酸(植物生长激素)、3-吲哚乙醇、DL-色氨酸及D-色氨酸等物质的关键前体,且自身也是神经系统的治疗药物,在农业、食品及医药领域具有广泛用途,应用前景广阔。传统化学法合成IPA需要耗用大量的碱和吡啶醛,价格昂贵,且反应条件苛刻、产物纯化繁琐、产率不高,副产物存在环境污染风险。利用L-氨基酸氧化酶氧化脱氨也是一种合成IPA的重要方法,但副产物过氧化氢会导致IPA的降解,收率及纯度均难以保证。专利CN200880104143.X利用大肠杆菌工程表达来源于雷氏普罗威登斯菌(Providencia rettgeri)AJ2770菌株的氨基酸氧化酶,转化L-色氨酸生产IPA,200mmol/L底物色氨酸反应体系中,IPA的最高浓度仅为129mM,且产物得率较低。3-Indolepyruvate (IPA) is an important intermediate compound and the key to the manufacture of 3-indoleacetic acid (plant growth hormone), 3-indoleethanol, DL-tryptophan and D-tryptophan. It is a precursor, and itself is a therapeutic drug for the nervous system. It has a wide range of uses in the fields of agriculture, food and medicine, and has broad application prospects. The traditional chemical synthesis of IPA requires a large amount of base and pyridine aldehyde, which is expensive, and has harsh reaction conditions, complicated product purification, low yield, and the risk of environmental pollution by by-products. Oxidative deamination using L-amino acid oxidase is also an important method for synthesizing IPA, but the by-product hydrogen peroxide will lead to the degradation of IPA, and the yield and purity are difficult to guarantee. Patent CN200880104143.X utilizes Escherichia coli engineering to express the amino acid oxidase derived from Providencia rettgeri AJ2770 strain, transforms L-tryptophan to produce IPA, and in the 200mmol/L substrate tryptophan reaction system, The highest concentration of IPA was only 129 mM, and the product yield was low.
转氨酶(Transaminase)又称氨基转移酶(Aminotransferase),催化氨基和酮基之间的氨基转移转氨酶,可以利用廉价原料L-色氨酸通过转氨基作用生产IPA,反应过程中无需通氧,亦不产生破坏酮酸稳定性的副产物(如过氧化氢),极具应用前景。Transaminase (Transaminase), also known as aminotransferase (Aminotransferase), catalyzes the aminotransferase between the amino group and the ketone group, and can use the cheap raw material L-tryptophan to produce IPA through transamination. It produces by-products (such as hydrogen peroxide) that destabilize ketoacids, which has great application prospects.
发明内容SUMMARY OF THE INVENTION
本发明要解决的技术问题在于提供一种产组氨醇磷酸氨基转移酶突变体、重组菌及其全细胞作为催化剂,用于3-吲哚丙酮酸的合成。The technical problem to be solved by the present invention is to provide a histidine alcohol phosphate aminotransferase-producing mutant, recombinant bacteria and whole cells thereof as catalysts for the synthesis of 3-indolepyruvic acid.
本发明是通过如下技术方案实现的:The present invention is achieved through the following technical solutions:
本发明提供了一种组氨醇磷酸氨基转移酶突变体,组氨醇磷酸氨基转移酶基因来源于藤黄轮丝链霉菌菌株HY61(Streptomyces luteoverticillatus)CGMCC15060,其核苷酸序列如SEQ ID NO:1所示,氨基酸序列如SEQ ID NO:2所示。所述突变体是在SEQ ID NO:2所示氨基酸序列第66位、第138位、第197位、第226位、第311位发生单突变或多位点突变获得的。The invention provides a histidine phosphate aminotransferase mutant, the histidine phosphate aminotransferase gene is derived from Streptomyces luteoverticillatus strain HY61 (Streptomyces luteoverticillatus) CGMCC15060, and its nucleotide sequence is such as SEQ ID NO: 1, the amino acid sequence is shown in SEQ ID NO: 2. The mutant is obtained by single mutation or multi-site mutation at the 66th position, 138th position, 197th position, 226th position and 311th position of the amino acid sequence shown in SEQ ID NO: 2.
进一步,所述突变体为下列之一,第66位缬氨酸突变为异亮氨酸(hisC-V66I)、第138位天冬酰胺突变为谷氨酰胺(hisC-N138Q)、第197位丝氨酸突变为组氨酸(hisC-S197H)或第226位脯氨酸突变为苯丙氨酸及第311位精氨酸突变为酪氨酸(hisC-P226F-R311Y)的组氨醇磷酸氨基转移酶突变体,更优选突变体为hisC-P226F-R311Y。Further, the mutant is one of the following, the 66th valine is mutated to isoleucine (hisC-V66I), the 138th asparagine is mutated to glutamine (hisC-N138Q), the 197th serine Histidine phosphate aminotransferase mutated to histidine (hisC-S197H) or proline 226 to phenylalanine and arginine 311 to tyrosine (hisC-P226F-R311Y) The mutant, more preferably the mutant is hisC-P226F-R311Y.
本发明还涉及一种所述组氨醇磷酸氨基转移酶突变体的编码基因。The present invention also relates to a gene encoding the histidine alcohol phosphate aminotransferase mutant.
本发明提供含有所述编码基因的工程菌。The present invention provides engineered bacteria containing the encoded gene.
本发明还提供一种所述组氨醇磷酸氨基转移酶突变体在催化L-色氨酸合成3-吲哚丙酮酸中的应用。The present invention also provides an application of the histidine alcohol phosphate aminotransferase mutant in catalyzing the synthesis of 3-indolepyruvate from L-tryptophan.
进一步,所述的应用方法为以含组氨醇磷酸氨基转移酶突变体基因的工程菌经发酵离心收获的菌体细胞作为全细胞催化剂,以L-色氨酸为底物,以L-色氨酸摩尔浓度1.2倍的丙酮酸为氨基受体,加入25mg/L的辅酶磷酸吡哆醛,1g/L的稳定保护剂的转化体系中,氨水调节pH为7.5,通氮气驱氧,温度30~40℃的条件下反应生产3-吲哚丙酮酸。Further, the described application method is to use the bacterial cell harvested by fermentation and centrifugation of the engineered bacteria containing the histidine alcohol phosphate aminotransferase mutant gene as a whole-cell catalyst, use L-tryptophan as a substrate, and use L-chromogen as a substrate. Pyruvate with an amino acid molar concentration of 1.2 times is an amino acceptor, adding 25mg/L coenzyme pyridoxal phosphate, 1g/L stabilizing protective agent to the conversion system, ammonia water is adjusted to pH 7.5, nitrogen is used to drive oxygen, and the temperature is 30 The reaction produces 3-indolepyruvic acid under the condition of ~40°C.
进一步,所述转化体系中,催化剂的用量以湿菌体重量计为10~40g/L,底 物浓度为50~200mM,丙酮酸浓度为60~240mM。Further, in the transformation system, the amount of catalyst used is 10-40 g/L in terms of wet cell weight, the substrate concentration is 50-200 mM, and the pyruvate concentration is 60-240 mM.
进一步,含组氨醇磷酸氨基转移酶突变体基因的工程菌按如下方法制备:将含组氨醇磷酸氨基转移酶突变体基因的重组大肠杆菌接入LB斜面培养基37℃培养12~18h;接1环斜面菌种于LB液体种子培养基,37℃、180r/min振荡培养4~10h;3L发酵罐中装入2.0L培养基,以体积比2~12%接种量将种子液接入发酵培养基,初始转速220r/min,初始通气流量为1.0L/min,随着菌体浓度增加调节转速与通气流量,以维持溶氧值在20~30%空气饱和度,用质量体积比为25%氨水调节pH值稳定在6.7,37℃培养4~12h后加入乳糖至终浓度为1~5g/L并降温至20~30℃诱导表达;发酵过程中流加500g/L的甘油溶液维持甘油浓度在5~10g/L发酵结束后10000r/min、4℃离心10min收集菌体,无菌生理盐水洗涤菌体两次,得组氨醇磷酸氨基转移酶突变体全细胞催化剂。Further, the engineered bacteria containing the histidine alcohol phosphate aminotransferase mutant gene are prepared as follows: the recombinant Escherichia coli containing the histidine alcohol phosphate aminotransferase mutant gene is inserted into the LB slant medium and cultured at 37°C for 12 to 18 hours; Connect 1 ring of slanted inoculum to LB liquid seed medium, shake at 37°C and 180r/min for 4-10h; put 2.0L of medium into a 3L fermenter, and insert the seed liquid with a volume ratio of 2-12% of the inoculum. Fermentation medium, the initial rotation speed is 220r/min, and the initial ventilation flow rate is 1.0L/min. With the increase of bacterial concentration, the rotation speed and ventilation flow rate are adjusted to maintain the dissolved oxygen value at 20-30% air saturation. The mass-volume ratio is 25% ammonia water was used to adjust the pH value to be stable at 6.7. After culturing at 37°C for 4-12h, lactose was added to the final concentration of 1-5g/L and cooled to 20-30°C to induce expression; during the fermentation process, 500g/L glycerol solution was added to maintain glycerol. After the fermentation at a concentration of 5-10 g/L, the cells were collected by centrifugation at 10,000 r/min and 4°C for 10 min, and washed twice with sterile saline to obtain histidine alcohol phosphate aminotransferase mutant whole-cell catalysts.
进一步,所述的LB斜面培养基的成分及终浓度:酵母浸粉5g/L,蛋白胨10g/L,NaCl 5g/L,氨苄西林100mg/L,琼脂20g/L,pH7.0~7.2,121℃高压蒸汽灭菌20min;Further, the composition and final concentration of the LB slant medium: yeast extract powder 5g/L, peptone 10g/L, NaCl 5g/L, ampicillin 100mg/L, agar 20g/L, pH7.0~7.2, 121 ℃ high pressure steam sterilization for 20min;
进一步,所述的LB液体种子培养基的成分及终浓度:酵母浸粉5g/L,蛋白胨10g/L,NaCl 5g/L,氨苄西林100mg/L,pH7.0~7.2,121℃高压蒸汽灭菌20min;Further, the composition and final concentration of the LB liquid seed medium: yeast extract powder 5g/L, peptone 10g/L, NaCl 5g/L, ampicillin 100mg/L, pH7.0~7.2, 121 ℃ of high pressure steam sterilization bacteria 20min;
进一步,所述的发酵培养基的成分及终浓度:甘油20g/L,蛋白胨20g/L,酵母浸粉5g/L,MgSO 4 2g/L,KH 2PO 4 12.5g/L,(NH 4) 2SO 4 2g/L,柠檬酸1g/L,玉米浆干粉3g/L,CaCl 2 1g/L,D-生物素20μg/L,pH6.7~7.0,121℃高压蒸汽灭菌20min。 Further, the composition and final concentration of the fermentation medium: glycerol 20g/L, peptone 20g/L, yeast extract 5g/L, MgSO 4 2g/L, KH 2 PO 4 12.5g/L, (NH 4 ) 2 SO 4 2g/L, citric acid 1g/L, corn steep liquor powder 3g/L, CaCl 2 1g/L, D-biotin 20μg/L, pH 6.7~7.0, 121 ℃ high pressure steam sterilization for 20min.
进一步,所述的稳定保护剂为亚硫酸钠、植酸中的一种或组合使用。Further, the stabilizing protective agent is one or a combination of sodium sulfite and phytic acid.
本发明与现有技术相比的有益效果是:The beneficial effects of the present invention compared with the prior art are:
本发明采用易错PCR技术成功突变来源于藤黄轮丝链霉菌的组氨醇磷酸氨基转移酶并构建工程菌株,筛选到的突变体酶活较原始最高提高120%,并用于3-吲哚丙酮酸的酶法合成,通过充氮保护和稳定剂的配合使用,有效提高了3-吲哚丙酮酸的稳定性,产物浓度最高可达179.8mM,转化率最大可达89.9%。同时本发明所述的生产方法所使用的原料廉价易得,且生产工艺简单易行、生产成本较低。建立的全细胞转化体系,解决了化学法合成IPA的反应条件苛刻、且产物纯化繁琐、产率不高,副产物存在环境污染风险的问题及L-氨基酸氧化酶副产物过氧化氢对产物的破坏影响,实现了高产率绿色生产IPA。The invention adopts the error-prone PCR technology to successfully mutate the histidine alcohol phosphate aminotransferase derived from Streptomyces garciniae and constructs an engineering strain. The screened mutant enzyme activity is up to 120% higher than the original, and is used for 3-indole For the enzymatic synthesis of pyruvate, the stability of 3-indolepyruvic acid is effectively improved through the combined use of nitrogen-filled protection and stabilizer. At the same time, the raw materials used in the production method of the present invention are cheap and easy to obtain, the production process is simple and feasible, and the production cost is low. The established whole-cell transformation system solves the problems of harsh reaction conditions for chemical synthesis of IPA, complicated product purification, low yield, environmental pollution risks of by-products, and the influence of L-amino acid oxidase by-product hydrogen peroxide on the product. Destroy the impact and achieve high-yield green production of IPA.
具体实施方式detailed description
下面通过实施例来对本发明的技术方案做进一步解释,但本发明的保护范围不受实施例任何形式上的限制。The technical solutions of the present invention are further explained below through the examples, but the protection scope of the present invention is not limited in any form by the examples.
实施例1:表达载体和工程菌构建Example 1: Construction of expression vector and engineered bacteria
根据藤黄轮丝链霉菌菌株HY61,生物保藏号为CGMCC 15060(该菌株在申请日之前已经进行生物保藏并在专利2018100327172中公开)基因hisC序列(SEQ ID No.1)设计含有Nco I酶切位点的上游引物hisC-NcoI-F:5′-aaccatggcaatgacgcgattacacgagctcc-3′,和含有Xho I酶切位点的下游引物hisC-XhoI-R:According to the strain HY61 of Streptomyces garcinata, the biological deposit number is CGMCC 15060 (this strain has been biologically deposited and disclosed in the patent 2018100327172 before the application date) gene hisC sequence (SEQ ID No. 1) is designed to contain Nco I digestion The upstream primer of the site hisC-NcoI-F: 5′-aaccatggcaatgacgcgattacacgagctcc-3′, and the downstream primer hisC-XhoI-R containing the Xho I restriction site:
5′-aactcgagtcaggcggccgccggtccggcg-3′,黑色斜体为酶切位点。利用细菌基因组DNA提取试剂盒提取得到藤黄轮丝链轮丝菌基因组DNA,并以该基因组DNA为模板进行PCR扩增,PCR反应体系包括2×GC Buffer I 25μL,dNTP Mix 8μL,TaKaRa LA Taq 0.5μL,模板0.5μL,上下游引物各1.0μL,用dd H 2O补足至50μL。PCR反应参数为:94℃1min,1个循环;94℃30s,60℃30s,72℃2min,30个循环;72℃延伸5min,1个循环。PCR扩增产物用1%的琼脂 糖凝胶检测,并用AxyPrep DNA凝胶回收试剂盒纯化目标DNA片段。用Nco I和Xho I分别酶切载体pET32a及片段,然后用T4DNA连接酶将hisC片段与载体连接并转化E.coli DH5α。阳性克隆利用菌落PCR和进行酶切鉴定验证正确后,获得pET32a-hisC重组载体。 5′-aactcgagtcaggcggccgccggtccggcg-3′, the black italic is the restriction site. Bacterial genomic DNA extraction kit was used to extract the genomic DNA of Streptomyces garcinata, and the genomic DNA was used as a template for PCR amplification. The PCR reaction system included 2×GC Buffer I 25 μL, dNTP Mix 8 μL, TaKaRa LA Taq 0.5 μL, template 0.5 μL, upstream and downstream primers 1.0 μL each, supplemented to 50 μL with dd H 2 O. PCR reaction parameters were: 94°C for 1 min, 1 cycle; 94°C for 30 s, 60°C for 30 s, 72°C for 2 min, 30 cycles; 72°C for 5 min, 1 cycle. PCR amplification products were detected by 1% agarose gel, and target DNA fragments were purified by AxyPrep DNA gel recovery kit. The vector pET32a and its fragment were digested with Nco I and Xho I, respectively, and then the hisC fragment was ligated with the vector with T4 DNA ligase and transformed into E. coli DH5α. After the positive clones were verified by colony PCR and enzyme digestion, the pET32a-hisC recombinant vector was obtained.
以重组载体pET32a-hisC作为模板,利用易错PCR方法进行扩增。易错PCR的反应体系为:PCR Grade Water 39μL,10×TITANIUM Taq Buffer 5μL,MnSO4(8mM)1μL,dGTP(2mM)1μL,50×Diversify dNTP Mix 1μL,Primer mix 1μL,模板1μL,TITANIUM Taq Polym 1μL,共50μL体系(其中反应体系中的Primer mix为实例1中所述上下游引物各0.5μL的混合溶液)。易错PCR反应条件为:94℃30s,1个循环;94℃30s,68℃1min30s,25个循环;68℃1min,1个循环。将易错PCR扩增产物用1%的琼脂糖凝胶检测,并用AxyPrep DNA凝胶回收试剂盒进行纯化。用Nco I和Xho I分别酶切载体pET32a及扩增产物,然后用T4DNA连接酶将扩增产物与载体连接,将连接后的重组载体热击转入E.coli BL21(DE3)感受态细胞,并置于37℃,200r/min条件下培养1h进行活化,将活化后重组细胞涂布于含0.1mg/mL氨苄西林抗性的LB平板上,37℃倒置培养过夜,获得组氨醇磷酸氨基转移酶突变体表达文库。The recombinant vector pET32a-hisC was used as a template for amplification by error-prone PCR. The reaction system of error-prone PCR is: PCR Grade Water 39μL, 10×TITANIUM Taq Buffer 5μL, MnSO4 (8mM) 1μL, dGTP (2mM) 1μL, 50×Diversify dNTP Mix 1μL, Primer mix 1μL, Template 1μL, TITANIUM Taq Polym 1μL , a total of 50 μL of the system (wherein the Primer mix in the reaction system is a mixed solution of 0.5 μL of each of the upstream and downstream primers described in Example 1). The error-prone PCR reaction conditions were: 94°C for 30s, 1 cycle; 94°C for 30s, 68°C for 1min30s, 25 cycles; 68°C for 1min, 1 cycle. Error-prone PCR amplification products were detected on a 1% agarose gel and purified using the AxyPrep DNA Gel Recovery Kit. The vector pET32a and the amplified product were digested with Nco I and Xho I respectively, and then the amplified product was connected with the vector with T4 DNA ligase, and the connected recombinant vector was thermally transferred into E.coli BL21 (DE3) competent cells, The cells were incubated at 37°C at 200 r/min for 1 h for activation, and the activated recombinant cells were spread on LB plates containing 0.1 mg/mL ampicillin resistance, and incubated overnight at 37°C upside down to obtain histidine alcohol amino phosphate. Transferase mutant expression library.
从获得的组氨醇磷酸氨基转移酶突变体表达文库菌落中利用高通量筛选方法,从这些单菌落中筛选高活性突变体菌株。其具体筛选方法为:从平板上随机挑取600个单菌落,接入96深孔板,培养基为LB液体培养基,37℃,180r/min培养9h后,离心收集菌体,去掉上清培养基后加入发酵培养基,37℃,220r/min培养6h后加入乳糖至终浓度为2g/L并降温至20℃诱导表达;离心收集菌体,测定酶活。标准酶活检测体系:25g/L湿菌体、50mM底物L-色氨酸、25mg/L辅酶磷酸吡哆醛、60mM丙酮酸,反应介质为pH 7.5的磷酸盐缓冲液,总体系为1mL。 单位酶活的定义:在标准的反应条件下,每分钟生成1μmol 3-吲哚丙酮酸所需要的酶量为一个酶活单位U。筛选得到4株高活性组氨醇磷酸氨基转移酶突变菌株,经测序,分别为SEQ ID NO:2所示氨基酸序列中第66位缬氨酸突变为异亮氨酸(hisC-V66I)、第138位天冬酰胺突变为谷氨酰胺(hisC-N138Q)、第197位丝氨酸突变为组氨酸(hisC-S197H)、第266位脯氨酸突变为苯丙氨酸及第311位精氨酸突变为酪氨酸(hisC-P226F-R311Y)的组氨醇磷酸氨基转移酶突变体,对应的工程菌株分别为E.coli BL21(DE3)/pET32a-hisC-V66I、E.coli BL21(DE3)/pET32a-hisC-N138Q、E.coli BL21(DE3)/pET32a-hisC-S197H、E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y。其中活性最高的是工程菌株E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y(表1)。From the obtained histidine phosphate aminotransferase mutant expression library colonies, high-throughput screening methods were used to screen high-activity mutant strains from these single colonies. The specific screening method is as follows: randomly pick 600 single colonies from the plate, insert it into a 96-deep-well plate, the medium is LB liquid medium, cultivate at 37°C for 9 hours at 180 r/min, collect the bacteria by centrifugation, and remove the supernatant. Fermentation medium was added after the medium, cultured at 37°C, 220r/min for 6h, lactose was added to the final concentration of 2g/L, and the temperature was lowered to 20°C to induce expression; the cells were collected by centrifugation, and the enzyme activity was determined. Standard enzyme activity detection system: 25g/L wet bacterial cells, 50mM substrate L-tryptophan, 25mg/L coenzyme pyridoxal phosphate, 60mM pyruvate, the reaction medium is phosphate buffer at pH 7.5, and the total system is 1mL . Definition of unit enzyme activity: Under standard reaction conditions, the amount of enzyme required to generate 1 μmol of 3-indolepyruvate per minute is one unit of enzyme activity U. Four highly active histidine alcohol phosphate aminotransferase mutant strains were obtained by screening, and after sequencing, the 66th valine in the amino acid sequence shown in SEQ ID NO: 2 was mutated to isoleucine (hisC-V66I), the Asparagine 138 was mutated to glutamine (hisC-N138Q), serine 197 was mutated to histidine (hisC-S197H), proline 266 was mutated to phenylalanine, and arginine 311 was mutated Histidine alcohol phosphate aminotransferase mutants mutated to tyrosine (hisC-P226F-R311Y), the corresponding engineering strains are E.coli BL21(DE3)/pET32a-hisC-V66I, E.coli BL21(DE3) /pET32a-hisC-N138Q, E.coli BL21(DE3)/pET32a-hisC-S197H, E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y. Among them, the engineering strain E. coli BL21(DE3)/pET32a-hisC-P226F-R311Y had the highest activity (Table 1).
表1组氨醇磷酸氨基转移酶突变体酶活Table 1 Histidine alcohol phosphate aminotransferase mutant enzyme activity
Figure PCTCN2020118927-appb-000001
Figure PCTCN2020118927-appb-000001
实施例2:利用重组菌发酵生产组氨醇磷酸氨基转移酶突变体(hisC-N138Q、hisC-P226F-R311Y)及酶法转化L-色氨酸生产IPAExample 2: Production of histidine alcohol phosphate aminotransferase mutants (hisC-N138Q, hisC-P226F-R311Y) by recombinant bacteria fermentation and enzymatic transformation of L-tryptophan to produce IPA
(1)分别将E.coli BL21(DE3)/pET32a-hisC-N138Q、E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y接入LB斜面培养基37℃培养18h;接1环斜面菌种于LB液体种子培养基,37℃、180r/min振荡培养9h;3L发酵罐中装入2.0L培养基,以体积比4%接种量将种子液接入发酵培养基,初始转速220r/min,初始通气流量为1.0L/min,随着菌体浓度增加调节转速与通气流量,以维持溶氧值在20~30%空气饱和度,用质量体积比为25%氨水调节pH值稳定在6.7,37℃培养6h后加入乳糖至终浓度为2g/L并降温至20℃诱导表达;发酵过程中流加500g/L的甘油溶液维持甘油浓度在5~10g/L发酵结束后10000r/min、4℃离心10min收集 菌体,无菌生理盐水洗涤菌体两次,分别得到E.coli BL21(DE3)/pET32a-hisC-N138Q、E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y的全细胞催化剂。(1) E.coli BL21(DE3)/pET32a-hisC-N138Q and E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y were respectively inserted into LB slant medium and cultured at 37℃ for 18h; Planted in LB liquid seed medium, 37°C, 180r/min shaking culture for 9h; 2.0L medium was placed in a 3L fermenter, the seed liquid was inserted into the fermentation medium at a volume ratio of 4% inoculum, and the initial speed was 220r/min , the initial ventilation flow is 1.0L/min, and the speed and ventilation flow are adjusted with the increase of bacterial concentration to maintain the dissolved oxygen value at 20-30% air saturation, and the pH value is stabilized at 6.7 with a mass-volume ratio of 25% ammonia water. , after culturing at 37°C for 6h, add lactose to a final concentration of 2g/L and cool down to 20°C to induce expression; during the fermentation process, 500g/L glycerol solution was added to maintain the glycerol concentration at 5-10g/L after fermentation, 10000r/min, 4 The cells were collected by centrifugation at ℃ for 10 min, and the cells were washed twice with sterile normal saline to obtain the complete and complete samples of E. Cell Catalyst.
(2)利用组氨醇磷酸氨基转移酶突变体全细胞催化生产3-吲哚丙酮酸,其转化条件为:配制50mM L-色氨酸溶液2L,加入色氨酸摩尔浓度1.2倍的丙酮酸和25mg/L的磷酸吡哆醛,1g/L的植酸,氨水调节pH为7.5,加入湿菌体10g,以0.5L/min的流速通氮气驱氧15min,维持温度35℃,在3L发酵罐上转化3h,以E.coli BL21(DE3)/pET32a-hisC-N138Q为催化剂的IPA浓度为45.7mM,摩尔转化率为91.4%;以E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y为催化剂的IPA浓度为47.6mM,摩尔转化率为95.2%。(2) The whole cell catalyzed production of 3-indolepyruvate using histidine alcohol phosphate aminotransferase mutant, the transformation conditions are: prepare 2L of 50mM L-tryptophan solution, add pyruvate with a tryptophan molar concentration of 1.2 times and 25mg/L of pyridoxal phosphate, 1g/L of phytic acid, ammonia water to adjust pH to 7.5, add 10g of wet cells, flow nitrogen to drive oxygen at a flow rate of 0.5L/min for 15min, maintain the temperature at 35°C, and ferment at 3L. Transformation on the tank for 3h, the IPA concentration of E.coli BL21(DE3)/pET32a-hisC-N138Q as catalyst was 45.7mM, and the molar conversion rate was 91.4%; E.coli BL21(DE3)/pET32a-hisC-P226F- The IPA concentration of R311Y as the catalyst was 47.6 mM, and the molar conversion was 95.2%.
实施例3:利用重组菌发酵生产组氨醇磷酸氨基转移酶突变体(hisC-P226F-R311Y)及酶法转化L-色氨酸生产IPAExample 3: Production of histidine alcohol phosphate aminotransferase mutant (hisC-P226F-R311Y) by recombinant bacteria fermentation and enzymatic transformation of L-tryptophan to produce IPA
(1)将基因工程菌E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y接入LB斜面培养基37℃培养15h;接1环斜面菌种于LB液体种子培养基,37℃、180r/min振荡培养10h;3L发酵罐中装入2.0L培养基,以体积比5%接种量将种子液接入发酵培养基,初始转速220r/min,初始通气流量为1.0L/min,随着菌体浓度增加调节转速与通气流量,以维持溶氧值在20~30%空气饱和度,用质量体积比为25%氨水调节pH值稳定在6.7,37℃培养4h后加入乳糖至终浓度为1g/L并降温至22℃诱导表达;发酵过程中流加500g/L的甘油溶液维持甘油浓度在5~10g/L,发酵结束后10000r/min、4℃离心10min收集菌体,无菌生理盐水洗涤菌体两次,得全细胞催化剂。(1) The genetically engineered bacteria E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y was inserted into LB slant medium for 15 hours at 37°C; then a ring of slant strains was placed in LB liquid seed medium at 37°C, 180r /min shaking culture for 10h; 2.0L medium was placed in the 3L fermenter, the seed liquid was inserted into the fermentation medium at a volume ratio of 5% inoculum, the initial speed was 220r/min, and the initial ventilation flow was 1.0L/min. The concentration of bacteria was increased to adjust the rotational speed and ventilation flow to maintain the dissolved oxygen value at 20-30% air saturation. The pH value was adjusted to 6.7 with a mass-volume ratio of 25% ammonia water. After culturing at 37 °C for 4 hours, lactose was added to the final concentration of 1 g/L and cooled to 22 °C to induce expression; during the fermentation process, 500 g/L glycerol solution was added to maintain the glycerol concentration at 5-10 g/L. After the fermentation, the cells were collected by centrifugation at 10000 r/min and 4 °C for 10 min, and sterile saline was used. The cells were washed twice to obtain the whole cell catalyst.
(2)利用组氨醇磷酸氨基转移酶突变体(hisC-P226F-R311Y)全细胞催化生产3-吲哚丙酮酸,其转化条件为:配制100mM L-色氨酸溶液2L,加入色氨酸摩尔浓度1.2倍的丙酮酸和25mg/L的磷酸吡哆醛,1g/L的亚硫酸钠,氨水调节 pH为7.5,加入湿菌体20g,以0.5L/min的流速通氮气驱氧15min,维持温度35℃,在3L发酵罐上转化5h,IPA浓度为87.4mM,摩尔转化率为87.4%。(2) The whole cell catalyzed production of 3-indolepyruvic acid using histidine alcohol phosphate aminotransferase mutant (hisC-P226F-R311Y), the transformation conditions are: prepare 2L of 100mM L-tryptophan solution, add tryptophan Pyruvate with a molar concentration of 1.2 times, pyridoxal phosphate 25mg/L, sodium sulfite 1g/L, ammonia water to adjust the pH to 7.5, add 20g of wet bacteria, flow nitrogen to drive oxygen at a flow rate of 0.5L/min for 15min, and maintain the temperature At 35°C, the transformation was carried out on a 3L fermentor for 5h, the IPA concentration was 87.4mM, and the molar conversion rate was 87.4%.
实施例4:利用重组菌发酵生产组氨醇磷酸氨基转移酶突变体(hisC-P226F-R311Y)及酶法转化L-色氨酸生产IPAExample 4: Production of histidine alcohol phosphate aminotransferase mutant (hisC-P226F-R311Y) by recombinant bacteria fermentation and enzymatic transformation of L-tryptophan to produce IPA
(1)将基因工程菌E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y接入LB斜面培养基37℃培养15h;接1环斜面菌种于LB液体种子培养基,37℃、180r/min振荡培养10h;3L发酵罐中装入2.0L培养基,以体积比5%接种量将种子液接入发酵培养基,初始转速220r/min,初始通气流量为1.0L/min,随着菌体浓度增加调节转速与通气流量,以维持溶氧值在20~30%空气饱和度,用质量体积比为25%氨水调节pH值稳定在6.7,37℃培养4h后加入乳糖至终浓度为1g/L并降温至22℃诱导表达;发酵过程中流加500g/L的甘油溶液维持甘油浓度在5~10g/L,发酵结束后10000r/min、4℃离心10min收集菌体,无菌生理盐水洗涤菌体两次,得全细胞催化剂。(1) The genetically engineered bacteria E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y was inserted into LB slant medium for 15 hours at 37°C; then a ring of slant strains was placed in LB liquid seed medium at 37°C, 180r /min shaking culture for 10h; 2.0L medium was placed in the 3L fermenter, the seed liquid was inserted into the fermentation medium at a volume ratio of 5% inoculum, the initial speed was 220r/min, and the initial ventilation flow was 1.0L/min. The concentration of bacteria was increased to adjust the rotational speed and ventilation flow to maintain the dissolved oxygen value at 20-30% air saturation. The pH value was adjusted to 6.7 with a mass-volume ratio of 25% ammonia water. After culturing at 37 °C for 4 hours, lactose was added to the final concentration of 1 g/L and cooled to 22 °C to induce expression; during the fermentation process, 500 g/L glycerol solution was added to maintain the glycerol concentration at 5-10 g/L. After the fermentation, the cells were collected by centrifugation at 10000 r/min and 4 °C for 10 min, and sterile saline was used. The cells were washed twice to obtain the whole cell catalyst.
(2)利用组氨醇磷酸氨基转移酶突变体(hisC-P226F-R311Y)全细胞催化生产3-吲哚丙酮酸,其转化条件为:配制100mM L-色氨酸溶液2L,加入色氨酸摩尔浓度1.2倍的丙酮酸、25mg/L的磷酸吡哆醛,1g/L的亚硫酸钠、1g/L的植酸,氨水调节pH为7.5,加入湿菌体20g,以0.5L/min的流速通氮气驱氧15min,维持温度35℃,在3L发酵罐上转化5h,IPA浓度为92.2mM,摩尔转化率为92.2%。(2) The whole cell catalyzed production of 3-indolepyruvic acid using histidine alcohol phosphate aminotransferase mutant (hisC-P226F-R311Y), the transformation conditions are: prepare 2L of 100mM L-tryptophan solution, add tryptophan 1.2 times the molar concentration of pyruvate, 25mg/L of pyridoxal phosphate, 1g/L of sodium sulfite, 1g/L of phytic acid, ammonia water to adjust the pH to 7.5, add 20g of wet cells, and pass through at a flow rate of 0.5L/min. Nitrogen was used to drive oxygen for 15 minutes, the temperature was maintained at 35°C, and the reaction was carried out in a 3L fermenter for 5 hours. The concentration of IPA was 92.2 mM, and the molar conversion rate was 92.2%.
实施例5:利用重组菌发酵生产组氨醇磷酸氨基转移酶突变体(hisC-P226F-R311Y)及酶法转化L-色氨酸生产IPAExample 5: Production of histidine alcohol phosphate aminotransferase mutant (hisC-P226F-R311Y) by recombinant bacteria fermentation and enzymatic transformation of L-tryptophan to produce IPA
(1)将基因工程菌E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y接入LB斜面培养基37℃培养14h;接1环斜面菌种于LB液体种子培养基,37℃、180r/min振荡培养8h;3L发酵罐中装入2.0L培养基,以体积比5%接种量将种子液接入发 酵培养基,初始转速220r/min,初始通气流量为1.0L/min,随着菌体浓度增加调节转速与通气流量,以维持溶氧值在20~30%空气饱和度,用质量体积比为25%氨水调节pH值稳定在6.7,37℃培养4h后加入乳糖至终浓度为4g/L并降温至20℃诱导表达;发酵过程中流加500g/L的甘油溶液维持甘油浓度在5~10g/L,发酵结束后10000r/min、4℃离心10min收集菌体,无菌生理盐水洗涤菌体两次,得全细胞催化剂。(1) The genetically engineered bacteria E.coli BL21(DE3)/pET32a-hisC-P226F-R311Y was inserted into LB slant medium for 14 hours at 37°C; then a ring of slant strains was placed in LB liquid seed medium at 37°C, 180r /min shaking culture for 8h; 2.0L medium was placed in the 3L fermenter, the seed liquid was inserted into the fermentation medium at a volume ratio of 5% inoculum, the initial rotation speed was 220r/min, and the initial ventilation flow was 1.0L/min. The concentration of bacteria was increased to adjust the rotational speed and ventilation flow to maintain the dissolved oxygen value at 20-30% air saturation. The pH value was adjusted to 6.7 with a mass-volume ratio of 25% ammonia water. After culturing at 37 °C for 4 hours, lactose was added to the final concentration of 4g/L and cooled to 20°C to induce expression; during the fermentation process, 500g/L glycerol solution was added to maintain the glycerol concentration at 5-10g/L. After the fermentation, the cells were collected by centrifugation at 10,000r/min and 4°C for 10min, and sterile saline The cells were washed twice to obtain the whole cell catalyst.
(2)利用组氨醇磷酸氨基转移酶突变体(hisC-P226F-R311Y)全细胞催化生产3-吲哚丙酮酸,其转化条件为:配制200mM L-色氨酸溶液2L,加入色氨酸摩尔浓度1.2倍的丙酮酸、25mg/L的磷酸吡哆醛,1g/L的亚硫酸钠、1g/L的植酸,氨水调节pH为7.5,加入湿菌体30g,以0.5L/min的流速通氮气驱氧15min,维持温度37℃,在3L发酵罐上转化12h,IPA浓度为179.8mM,摩尔转化率为89.9%。(2) The whole cell catalyzed production of 3-indolepyruvic acid using histidine alcohol phosphate aminotransferase mutant (hisC-P226F-R311Y), the transformation conditions are: prepare 2L of 200mM L-tryptophan solution, add tryptophan 1.2 times molar concentration of pyruvate, 25mg/L pyridoxal phosphate, 1g/L sodium sulfite, 1g/L phytic acid, ammonia water to adjust the pH to 7.5, add 30g of wet cells, and pass through at a flow rate of 0.5L/min. Nitrogen was used to drive oxygen for 15 min, the temperature was maintained at 37 °C, and the reaction was carried out in a 3 L fermentor for 12 h. The concentration of IPA was 179.8 mM, and the molar conversion rate was 89.9%.
Figure PCTCN2020118927-appb-000002
Figure PCTCN2020118927-appb-000002
Figure PCTCN2020118927-appb-000003
Figure PCTCN2020118927-appb-000003

Claims (10)

  1. 一种组氨醇磷酸氨基转移酶突变体,其特征在于组氨醇磷酸氨基转移酶基因来源于藤黄轮丝链霉菌菌株HY61,其核苷酸序列如SEQ ID NO:1所示,氨基酸序列如SEQ ID NO:2所示;所述突变体是在SEQ ID NO:2所示氨基酸序列第66位、第138位、第197位、第226位、第311位发生单突变或多位点突变获得的,具体突变为第66位缬氨酸突变为异亮氨酸、第138位天冬酰胺突变为谷氨酰胺、第197位丝氨酸突变为组氨酸或第226位脯氨酸突变为苯丙氨酸及第311位精氨酸突变为酪氨酸。A kind of histidine alcohol phosphate aminotransferase mutant, it is characterized in that histidine alcohol phosphate aminotransferase gene is derived from Streptomyces garcinias strain HY61, its nucleotide sequence is as shown in SEQ ID NO: 1, the amino acid sequence As shown in SEQ ID NO: 2; the mutant is a single mutation or multiple sites at the 66th, 138th, 197th, 226th and 311th positions of the amino acid sequence shown in SEQ ID NO: 2 Obtained by mutation, the specific mutation is the mutation of valine at position 66 to isoleucine, the mutation of asparagine at position 138 to glutamine, the mutation of serine at position 197 to histidine, or the mutation of proline at position 226 to Phenylalanine and arginine at position 311 were mutated to tyrosine.
  2. 一种权利要求1所述组氨醇磷酸氨基转移酶突变体的编码基因。A gene encoding the histidine alcohol phosphate aminotransferase mutant of claim 1.
  3. 含有权利要求2所述编码基因的工程菌。The engineering bacteria containing the coding gene of claim 2.
  4. 权利要求1所述组氨醇磷酸氨基转移酶突变体在催化L-色氨酸合成3-吲哚丙酮酸中的应用。The application of the histidine alcohol phosphate aminotransferase mutant of claim 1 in catalyzing the synthesis of 3-indolepyruvate from L-tryptophan.
  5. 根据权利要求4所述的应用,其特征在于所述的应用方法为以含组氨醇磷酸氨基转移酶突变体基因的工程菌经发酵离心收获的菌体细胞作为全细胞催化剂,以L-色氨酸为底物,以L-色氨酸摩尔浓度1.2倍的丙酮酸为氨基受体,加入25mg/L的辅酶磷酸吡哆醛,1g/L的稳定保护剂的转化体系中,氨水调节pH为7.5,通氮气驱氧,温度30~40℃的条件下反应生产3-吲哚丙酮酸。The application according to claim 4, characterized in that the application method is to use the somatic cells harvested by fermentation and centrifugation of the engineered bacteria containing the histidine alcohol phosphate aminotransferase mutant gene as a whole-cell catalyst, and use L-color Amino acid as substrate, pyruvate with 1.2 times the molar concentration of L-tryptophan as amino acceptor, adding 25mg/L coenzyme pyridoxal phosphate, 1g/L stabilizing protective agent to the conversion system, ammonia water to adjust pH It is 7.5, and nitrogen is used to drive out oxygen, and 3-indolepyruvic acid is produced by reaction under the condition of temperature of 30-40 °C.
  6. 根据权利要求5所述的应用,其特征在于在转化体系中,催化剂的用量以湿菌体重量计为10~40g/L,底物浓度为50~200mM,丙酮酸浓度为60~240mM。The application according to claim 5, characterized in that in the transformation system, the amount of the catalyst is 10-40 g/L by wet cell weight, the substrate concentration is 50-200 mM, and the pyruvate concentration is 60-240 mM.
  7. 权利要求3所述的含组氨醇磷酸氨基转移酶突变体基因的工程菌的制备方法,其特征在于所述方法具体如下:将含组氨醇磷酸氨基转移酶突变体基因的重组大肠杆菌接入LB斜面培养基37℃培养12~18h;接1环斜面菌种于LB液体种子培养基,37℃、180r/min振荡培养4~10h;3L发酵罐中装入2.0L培养基,以体积比2~12%接种量将种子液接入发酵培养基,初始转速220r/min,初始通气流量 为1.0L/min,随着菌体浓度增加调节转速与通气流量,以维持溶氧值在20~30%空气饱和度,用质量体积比为25%氨水调节pH值稳定在6.7,37℃培养4~12h后加入乳糖至终浓度为1~5g/L并降温至20~30℃诱导表达;发酵过程中流加500g/L的甘油溶液维持甘油浓度在5~10g/L发酵结束后10000r/min、4℃离心10min收集菌体,无菌生理盐水洗涤菌体两次,得组氨醇磷酸氨基转移酶突变体全细胞催化剂。The preparation method of the engineered bacteria containing histidine phosphate aminotransferase mutant gene according to claim 3, it is characterized in that the method is specifically as follows: the recombinant Escherichia coli containing histidine phosphate aminotransferase mutant gene is connected Into LB slant medium at 37°C for 12-18h; connect 1 ring of slant strains to LB liquid seed medium, shake at 37°C, 180r/min for 4-10h; put 2.0L of medium in a 3L fermenter, and use the volume The seed liquid is connected to the fermentation medium at a ratio of 2 to 12% of the inoculum, the initial speed is 220r/min, and the initial ventilation flow is 1.0L/min. With the increase of bacterial concentration, the speed and ventilation flow are adjusted to maintain the dissolved oxygen value at 20 ~30% air saturation, adjust the pH value to be stable at 6.7 with 25% ammonia water in mass volume ratio, add lactose to the final concentration of 1~5g/L after culturing at 37℃ for 4~12h, and cool down to 20~30℃ to induce expression; During the fermentation process, 500g/L glycerol solution was added to maintain the glycerol concentration at 5-10g/L. After the fermentation was completed, the cells were collected by centrifugation at 10,000r/min and 4°C for 10min. The cells were washed twice with sterile saline to obtain histidine alcohol phosphate amino groups. Transferase mutant whole-cell catalysts.
  8. 根据权利要求7所述的方法,其特征在于所述的LB斜面培养基的成分及终浓度:酵母浸粉5g/L,蛋白胨10g/L,NaCl 5g/L,氨苄西林100mg/L,琼脂20g/L,pH7.0~7.2,121℃高压蒸汽灭菌20min;method according to claim 7, is characterized in that the composition and final concentration of described LB slant medium: yeast extract powder 5g/L, peptone 10g/L, NaCl 5g/L, ampicillin 100mg/L, agar 20g /L, pH7.0~7.2, 121℃ high pressure steam sterilization for 20min;
  9. 根据权利要求7所述的方法,其特征在于所述的LB液体种子培养基的成分及终浓度:酵母浸粉5g/L,蛋白胨10g/L,NaCl 5g/L,氨苄西林100mg/L,pH7.0~7.2,121℃高压蒸汽灭菌20min;method according to claim 7, is characterized in that the composition and final concentration of described LB liquid seed medium: yeast extract powder 5g/L, peptone 10g/L, NaCl 5g/L, ampicillin 100mg/L, pH7 .0~7.2, 121℃ high pressure steam sterilization for 20min;
  10. 根据权利要求7所述的方法,其特征在于所述的发酵培养基的成分及终浓度:甘油20g/L,蛋白胨20g/L,酵母浸粉5g/L,MgSO 4 2g/L,KH 2PO 4 12.5g/L,(NH 4) 2SO 4 2g/L,柠檬酸1g/L,玉米浆干粉3g/L,CaCl 2 1g/L,D-生物素20μg/L,pH6.7~7.0,121℃高压蒸汽灭菌20min;所述的稳定保护剂为亚硫酸钠、植酸中的一种或组合使用。 The method according to claim 7, characterized in that the composition and final concentration of the fermentation medium: glycerol 20g/L, peptone 20g/L, yeast extract 5g/L, MgSO 4 2g/L, KH 2 PO 4 12.5g/L, (NH 4 ) 2 SO 4 2g/L, citric acid 1g/L, corn steep liquor 3g/L, CaCl 2 1g/L, D-biotin 20μg/L, pH6.7~7.0, Sterilize with high pressure steam at 121° C. for 20 min; the stabilized protective agent is one or a combination of sodium sulfite and phytic acid.
PCT/CN2020/118927 2020-09-14 2020-09-29 Histidinol-phosphate aminotransferase mutant, engineering bacteria and use WO2022052191A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010962107.XA CN111996178B (en) 2020-09-14 2020-09-14 Histone alcohol phosphate aminotransferase mutant, engineering bacterium and application
CN202010962107.X 2020-09-14

Publications (1)

Publication Number Publication Date
WO2022052191A1 true WO2022052191A1 (en) 2022-03-17

Family

ID=73469330

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/118927 WO2022052191A1 (en) 2020-09-14 2020-09-29 Histidinol-phosphate aminotransferase mutant, engineering bacteria and use

Country Status (2)

Country Link
CN (4) CN111996178B (en)
WO (1) WO2022052191A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112592881B (en) * 2021-02-25 2021-06-11 中国科学院天津工业生物技术研究所 Engineering bacillus subtilis for high-efficiency exogenous protein expression and high-density culture
CN114634918B (en) * 2022-05-19 2022-10-28 鲁东大学 D-amino acid oxidase mutant, engineering bacteria and application
CN116286703B (en) * 2023-05-25 2023-08-08 鲁东大学 L-alanine dehydrogenase mutant, engineering bacterium and application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020771A2 (en) * 2000-09-09 2002-03-14 Degussa Ag Nucleotide sequences coding for the hisc2 gene
CN102027117A (en) * 2007-08-24 2011-04-20 味之素株式会社 Novel oxidase gene and method of producing 3-indole-pyruvic acid using the gene
CN107828753A (en) * 2017-11-30 2018-03-23 湖北工业大学 Polyclonal antibody of histidinol-phosphate aminotransferase and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525244B1 (en) * 1998-11-05 2003-02-25 E. I. Du Pont De Nemours And Company Plant histidinol-phosphate aminotransferase homologs
JPWO2004053111A1 (en) * 2002-12-12 2006-04-13 昭和電工株式会社 Method for selecting E. coli strain highly expressing foreign gene, E. coli mutant strain selected by the method, and method for producing enzyme and compound using the same
RU2006145712A (en) * 2006-12-22 2008-06-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) (RU) METHOD FOR PRODUCING L-AMINO ACIDS BY THE FERMENTATION METHOD USING BACTERIA HAVING AN INCREASED ABILITY FOR GYLICERINE DISPOSAL
RU2403286C2 (en) * 2008-04-04 2010-11-10 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) Mutant phosphoribosyl pyrophosphate synthetase, dna coding said synthetase, bacterium coding said dna, method of producing purine nucleosides and method of producing purine nucelotides
JP5521347B2 (en) * 2009-02-16 2014-06-11 味の素株式会社 L-amino acid producing bacterium and method for producing L-amino acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020771A2 (en) * 2000-09-09 2002-03-14 Degussa Ag Nucleotide sequences coding for the hisc2 gene
CN102027117A (en) * 2007-08-24 2011-04-20 味之素株式会社 Novel oxidase gene and method of producing 3-indole-pyruvic acid using the gene
CN107828753A (en) * 2017-11-30 2018-03-23 湖北工业大学 Polyclonal antibody of histidinol-phosphate aminotransferase and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE PROTEIN 1 March 2022 (2022-03-01), ANONYMOUS : "histidinol-phosphate transaminase [Streptomyces luteoverticillatus] ", XP055910998, retrieved from NCBI Database accession no. WP_126917656 *
HIROYUKIMIZUGUCHI ET AL.: "Characterization of histidinol phosphate aminotransferase from Escherichia coli", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - PROTEINS AND PROTEOMICS, vol. 1647, no. 1-2, 30 April 2003 (2003-04-30), XP004418006, DOI: 10.1016/S1570-9639(03)00082-7 *

Also Published As

Publication number Publication date
CN114015669B (en) 2023-01-03
CN114015670B (en) 2023-01-03
CN114015671A (en) 2022-02-08
CN114015669A (en) 2022-02-08
CN111996178B (en) 2022-01-28
CN114015670A (en) 2022-02-08
CN111996178A (en) 2020-11-27
CN114015671B (en) 2023-01-03

Similar Documents

Publication Publication Date Title
WO2022052191A1 (en) Histidinol-phosphate aminotransferase mutant, engineering bacteria and use
CN110607268B (en) Genetically engineered bacterium for high yield of L-valine and method for producing L-valine by fermentation
CN110468092B (en) Genetically engineered bacterium capable of producing L-valine at high yield, and construction method and application thereof
KR100626102B1 (en) L-Glutamic acid-producing bacterium and method for producing L-glutamic acid
CN111321193B (en) Method for asymmetrically preparing L-glufosinate-ammonium by redox through biological multi-enzyme coupling method
WO2018205563A1 (en) Method for producing tetrahydropyrimidine by fermenting recombinant corynebacterium glutamicum
CN114634918B (en) D-amino acid oxidase mutant, engineering bacteria and application
CN109735522B (en) L-aspartic acid-alpha-decarboxylase mutant and application thereof
CN109609478B (en) α -transaminase and mutant thereof and application thereof in asymmetric synthesis of L-glufosinate-ammonium
CN109609477B (en) Alpha-transaminase mutant and application thereof in asymmetric synthesis of L-glufosinate-ammonium
CN116286703B (en) L-alanine dehydrogenase mutant, engineering bacterium and application
CN116478942B (en) Isoeugenol monooxygenase mutant, engineering bacteria and application
CN111808829A (en) Gamma-glutamyl methylamine synthetase mutant and application thereof
CN114874959B (en) Genetically engineered bacterium, method and application for producing L-theanine by glucose secondary fermentation
CN106701649B (en) L-glutamine producing strain and method for producing L-glutamine
CN113621592B (en) Transaminase mutant and coding gene and application thereof
TW202202621A (en) Novel promoter and method of producing glutathione using the same
CN114921432B (en) Transaminase mutant, engineering bacteria thereof and application thereof
CN116606824B (en) Isoeugenol monooxygenase mutant IEM-F305W-L470E, engineering bacteria and application
CN109576200A (en) A kind of recombinant bacterium producing glutamate racemase and its construction method and application
CN112625993B (en) Preparation of alpha-ketoglutaric acid by microbial conversion method
CN110904086B (en) Tryptophanase mutant and application thereof
CN113373126B (en) Transaminase mutant and coding gene and application thereof
TWI786573B (en) Glutamate-cysteine ligase variant and method of producing glutathione using the same
CN106636251B (en) Method for high yield of D-ribose by using bacillus subtilis engineering bacteria

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20952978

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20952978

Country of ref document: EP

Kind code of ref document: A1